Personalis (PSNL) News Today $4.64 +0.11 (+2.43%) Closing price 04:00 PM EasternExtended Trading$4.64 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PSNL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Head to Head Contrast: Personalis (NASDAQ:PSNL) and Teva Pharmaceutical Industries (NYSE:TEVA)August 18 at 3:51 AM | americanbankingnews.comAnalyzing Assembly Biosciences (NASDAQ:ASMB) and Personalis (NASDAQ:PSNL)August 17 at 3:21 AM | americanbankingnews.comCathie Wood’s ARK Investment buys 133.3K shares of Personalis todayAugust 15, 2025 | msn.comPersonalis (NASDAQ:PSNL) Rating Lowered to Sell at Wall Street ZenAugust 10, 2025 | marketbeat.comQ3 Earnings Forecast for Personalis Issued By HC WainwrightAugust 10, 2025 | americanbankingnews.comWhat is HC Wainwright's Forecast for Personalis Q3 Earnings?August 9, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Downgraded by Wall Street Zen to "Sell"August 9, 2025 | americanbankingnews.comPersonalis, Inc. (NASDAQ:PSNL) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportAugust 8, 2025 | finance.yahoo.comPSNL | Personalis Inc. Annual Income Statement | MarketWatchAugust 7, 2025 | marketwatch.comPersonalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comPersonalis (NASDAQ:PSNL) Given New $8.50 Price Target at HC WainwrightAugust 7, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Posts Earnings Results, Beats Expectations By $0.02 EPSAugust 6, 2025 | marketbeat.comPersonalis (PSNL) Q2 Revenue Falls 24%August 6, 2025 | fool.comPersonalis, Inc. (PSNL) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comPersonalis reports Q2 EPS (23c), consensus (24c)August 5, 2025 | msn.comPersonalis Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | finance.yahoo.comPersonalis Q2 2025 Earnings PreviewAugust 5, 2025 | msn.comPersonalis (NASDAQ:PSNL) Shares Down 7.4% - What's Next?July 30, 2025 | marketbeat.comPersonalis (PSNL) Projected to Post Earnings on TuesdayJuly 30, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Receives Consensus Rating of "Buy" from AnalystsJuly 29, 2025 | marketbeat.comARK Investment Management LLC Has $25.23 Million Stake in Personalis, Inc. (NASDAQ:PSNL)July 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Sells 57,339 Shares of Personalis, Inc. (NASDAQ:PSNL)July 27, 2025 | marketbeat.comPersonalis to Announce Second Quarter 2025 Financial ResultsJuly 22, 2025 | businesswire.comPersonalis, Inc. (NASDAQ:PSNL) Stake Lifted by AIGH Capital Management LLCJuly 22, 2025 | marketbeat.comPersonalis, Inc. (PSNL) - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comPersonalis and Tempus extend cancer detection collaboration to 2029July 11, 2025 | investing.comPersonalis Expands Tempus Strategic Collaboration to Bring Ultra ...July 11, 2025 | morningstar.comMPersonalis (NASDAQ:PSNL) Shares Down 6.1% - Time to Sell?July 10, 2025 | marketbeat.comPersonalis, Tempus Expand Detection Test to Include Colorectal CancerJuly 9, 2025 | marketwatch.comStocks to Watch: Nurix Therapeutics, Personalis, WK KelloggJuly 9, 2025 | marketwatch.comPersonalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer PatientsJuly 9, 2025 | finance.yahoo.comPersonalis, Inc. (NASDAQ:PSNL) Stake Lessened by Sumitomo Mitsui Trust Group Inc.July 5, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Buy" by BrokeragesJuly 4, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Trading Down 3.5% - Here's WhyJuly 3, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Hits New 12-Month High - Here's WhyJuly 2, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Trading 6.4% Higher - Should You Buy?June 30, 2025 | marketbeat.comThe 13% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 394%June 18, 2025 | finance.yahoo.comPersonalis (NASDAQ:PSNL) Shares Up 7% - Should You Buy?June 18, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Stock Price Up 7.4% - Time to Buy?June 11, 2025 | marketbeat.comPersonalis: Ultra-Sensitive Tech, Ultra-Sensitive RisksJune 8, 2025 | seekingalpha.comPersonalis, Inc. (NASDAQ:PSNL) Shares Purchased by Two Sigma Investments LPJune 7, 2025 | marketbeat.comPersonalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCOJune 4, 2025 | finance.yahoo.comSquarepoint Ops LLC Has $530,000 Stock Position in Personalis, Inc. (NASDAQ:PSNL)June 4, 2025 | marketbeat.comPersonalis' NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCOJune 3, 2025 | businesswire.comPersonalis, Inc. (PSNL) ctDNA Test Predicts TNBC Relapse Risk Post-TherapyJune 3, 2025 | insidermonkey.comNew Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for RelapseJune 2, 2025 | finance.yahoo.comNew Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for RelapseJune 2, 2025 | businesswire.comMillennium Management LLC Has $7.61 Million Stock Position in Personalis, Inc. (NASDAQ:PSNL)May 28, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires 71,721 Shares of Personalis, Inc. (NASDAQ:PSNL)May 27, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Shares Bought by Williams Jones Wealth Management LLC.May 23, 2025 | marketbeat.com Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Email Address PSNL Media Mentions By Week PSNL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSNL News Sentiment▼0.120.47▲Average Medical News Sentiment PSNL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSNL Articles This Week▼33▲PSNL Articles Average Week Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VRDN News Today AVAH News Today TDOC News Today AHCO News Today OMDA News Today GRAL News Today PNTG News Today FTRE News Today FLGT News Today CDNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PSNL) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access